RDG.WA
Read Gene SA
Price:  
4.62 
PLN
Volume:  
1,453.00
Poland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RDG.WA WACC - Weighted Average Cost of Capital

The WACC of Read Gene SA (RDG.WA) is 8.4%.

The Cost of Equity of Read Gene SA (RDG.WA) is 8.65%.
The Cost of Debt of Read Gene SA (RDG.WA) is 7.00%.

Range Selected
Cost of equity 7.90% - 9.40% 8.65%
Tax rate 12.40% - 21.40% 16.90%
Cost of debt 7.00% - 7.00% 7.00%
WACC 7.8% - 9.1% 8.4%
WACC

RDG.WA WACC calculation

Category Low High
Long-term bond rate 5.5% 6.0%
Equity market risk premium 6.3% 7.3%
Adjusted beta 0.38 0.4
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.90% 9.40%
Tax rate 12.40% 21.40%
Debt/Equity ratio 0.09 0.09
Cost of debt 7.00% 7.00%
After-tax WACC 7.8% 9.1%
Selected WACC 8.4%

RDG.WA's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for RDG.WA:

cost_of_equity (8.65%) = risk_free_rate (5.75%) + equity_risk_premium (6.80%) * adjusted_beta (0.38) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.